Among his notable contributions is the development of the NAGI Stent, a widely adopted device for the drainage of pancreatic pseudocysts
Revvity is positioning its technologies as a connected engine for discovery
Backed by funding from an NIHR Doctoral Award, the guidance is focused on spotting abdominal tumours
The trial, dubbed MALBEC, marks the first in a broader late-phase development push for MK-8748, with a second NVAMD study expected to begin later this year
Beyond clinical trials, real-world evidence is adding weight to AbbVie’s claims
The new entity will operate with separate resources, funding, and operations, while BioNTech will contribute related rights and mRNA technologies to support its ambitious mission
The study is a collaboration between AIM, AstraZeneca, and Erasmus Medical Center in the Netherlands
The BEAR Implant is the first sports medicine device to carry a label claim related to lowering PTOA risk
Subscribe To Our Newsletter & Stay Updated